Tvardi Therapeutics, Inc. (TVRD): Capital Expenditures
$1.05M
Year ended 2024-12-31
+199.3%
3-year compound annual growth
n/m
5-year compound annual growth
+37.9%
10-year compound annual growth
| Period ended | Capital Expenditures | Change YoY | Source filing |
|---|---|---|---|
| 2024-12-31 | $1.05M | -56.0% | 2025-03-11, From 2024-01-01 |
| 2023-12-31 | $2.38M | n/m | 2025-03-11, From 2023-01-01 |
| 2022-12-31 | $43.0K | +10.3% | 2025-03-11, From 2022-01-01 |
| 2021-12-31 | $39.0K | -88.8% | 2024-03-06, From 2021-01-01 |
| 2020-12-31 | $349.0K | n/m | 2023-03-06, From 2020-01-01 |
| 2019-12-31 | $18.0K | -75.3% | 2022-03-01, From 2019-01-01 |
| 2018-12-31 | $73.0K | +25.9% | 2021-02-25, From 2018-01-01 |
| 2017-12-31 | $58.0K | -91.9% | 2020-02-27, From 2017-01-01 |
| 2016-12-31 | $717.0K | n/m | 2019-03-12, From 2016-01-01 |
| 2015-12-31 | $20.0K | -52.4% | 2018-03-15, From 2015-01-01 |
| 2014-12-31 | $42.0K | +740.0% | 2017-03-10, From 2014-01-01 |
| 2013-12-31 | $5.0K | n/a | 2016-03-11, From 2013-01-01 |